AAAAAA

   
Results: 1-11 |
Results: 11

Authors: ALTMAN LC MUNK Z SELTZER J NOONAN N SHINGO S ZHANG J REISS TF
Citation: Lc. Altman et al., A PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF MONTELUKAST, A CYSTEINYL LEUKOTRIENE-RECEPTOR ANTAGONIST, Journal of allergy and clinical immunology, 102(1), 1998, pp. 50-56

Authors: REISS TF CHERVINSKY P DOCKHORN RJ SHINGO S SEIDENBERG B EDWARDS TB
Citation: Tf. Reiss et al., MONTELUKAST, A ONCE-DAILY LEUKOTRIENE RECEPTOR ANTAGONIST, IN THE TREATMENT OF CHRONIC ASTHMA - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL, Archives of internal medicine, 158(11), 1998, pp. 1213-1220

Authors: ZHANG J CHERVINSKY P EDWARDS T DOCKHORN R NAYAK A NOONAN G HESS J SHINGO S REISS TF
Citation: J. Zhang et al., MONTELUKAST, A CYS LT(1) RECEPTOR ANTAGONIST, DECREASES PERIPHERAL-BLOOD EOSINOPHILS AND IMPROVES SIGNS AND SYMPTOMS OF ASTHMA OVER A 3 MONTH PERIOD, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1095-1095

Authors: ISHII H SHINGO S HARADA S HIRANO S IWATA Y HARA T YOSHIDA N FUJINO K SATO K
Citation: H. Ishii et al., INTERGRANULAR TRANSPORT-PROPERTIES IN C-AXIS ORIENTED YBA2CU3OY POLYCRYSTALLINE FILMS, Applied physics letters, 71(16), 1997, pp. 2367-2369

Authors: HILLINGSO J KJELDSEN J LAURITSEN K VONSPRECKELSEN S DEPRE M FRIEDMAN BS MALMSTROM K SHINGO S BUKHAVE K RASKMADSEN J
Citation: J. Hillingso et al., BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 335-341

Authors: HILLINGSO J KJELDSEN J LAURSEN LS LAURITSEN K VONSPRECKELSEN S DEPRE M FRIEDMAN BS MALMSTROM K SHINGO S BUKHAVE K RASKMADSEN J
Citation: J. Hillingso et al., SELECTIVE BLOCKADE OF RECTAL LEUKOTRIENE-B4 (LTB4) AND SYSTEMIC LEUKOTRIENE PRODUCTION BY A SINGLE, ORAL DOSE OF MK-591 IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Gastroenterology, 106(4), 1994, pp. 10000698-10000698

Authors: DEPRE M FRIEDMAN B VANHECKEN A DELEPELEIRE I TANAKA W DALLOB A SHINGO S PORRAS A LIN C DESCHEPPER PJ
Citation: M. Depre et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ORAL DOSES OF MK-0591, A 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 22-30

Authors: LASKIN OL PATTERSON PM SHINGO S LASSETER KC SHAMBLEN EC
Citation: Ol. Laskin et al., PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIP OF FAMOTIDINE - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL, Journal of clinical pharmacology, 33(7), 1993, pp. 636-639

Authors: MCCREA JB FRUNCILLO RJ HOLLAND SD CONROY JA SHINGO S SPECTOR R BJORNSSON TD
Citation: Jb. Mccrea et al., LOVASTATIN DOES NOT AFFECT ORAL GLUCOSE-TOLERANCE IN HYPERCHOLESTEROLEMIC PATIENTS, Journal of clinical pharmacology, 33(6), 1993, pp. 581-585

Authors: MURPHY MG SYTNIK B KOVACS TOG MERTZ H EWANIK D SHINGO S LIN JH GERTZ BJ WALSH JH
Citation: Mg. Murphy et al., THE GASTRIN-RECEPTOR ANTAGONIST L-365,260 INHIBITS STIMULATED ACID-SECRETION IN HUMANS, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 533-539

Authors: IMPENS N REISS TF TEAHAN JA DESMET M ROSSING TH SHINGO S JI Z SCHANDEVYL W VERBESSELT R DUPONT AG
Citation: N. Impens et al., ACUTE BRONCHODILATION WITH AN INTRAVENOUSLY ADMINISTERED LEUKOTRIENE-D(4) ANTAGONIST, MK-679, The American review of respiratory disease, 147(6), 1993, pp. 1442-1446
Risultati: 1-11 |